# FDA Approves Sunshine Lake Pharma Biologic Application The U.S. Food and Drug Administration has approved Biologics License Application (BLA) 761412 for Sunshine Lake Pharma Co Ltd, potentially expanding the company's market presence in the biologics sector and opening new revenue opportunities. The approval marks a significant milestone for the Chinese manufacturer as it seeks to strengthen its competitive position in the global biopharmaceutical market.